CVE-2020-36477

Description

An issue was discovered in Mbed TLS before 2.24.0. The verification of X.509 certificates when matching the expected common name (the cn argument of mbedtls_x509_crt_verify) with the actual certificate name is mishandled: when the subjecAltName extension is present, the expected name is compared to any name in that extension regardless of its type. This means that an attacker could impersonate a 4-byte or 16-byte domain by getting a certificate for the corresponding IPv4 or IPv6 address (this would require the attacker to control that IP address, though).

Category

5.9
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.21%
Vendor Advisory gentoo.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://github.com/ARMmbed/mbedtls/releases/tag/v2.24.0 third party advisory release notes
https://github.com/ARMmbed/mbedtls/issues/3498 third party advisory
https://security.gentoo.org/glsa/202301-08 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2020-36477?
CVE-2020-36477 has been scored as a medium severity vulnerability.
How to fix CVE-2020-36477?
To fix CVE-2020-36477, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-36477 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-36477 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.